Published in Chembiochem on December 04, 2014
Cyclin is degraded by the ubiquitin pathway. Nature (1991) 17.93
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 11.73
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood (2007) 3.67
The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure (2002) 3.44
Regulation of CD8+ T cell development by thymus-specific proteasomes. Science (2007) 3.11
A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature (1991) 2.84
Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol (2009) 2.82
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med (2009) 2.62
Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol (2005) 2.49
Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med (1998) 2.32
Second proteasome-related gene in the human MHC class II region. Nature (1991) 2.29
Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol (2012) 2.26
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity (2000) 2.10
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome. Blood (2009) 2.06
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell (2012) 1.83
Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem (2000) 1.83
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci U S A (2010) 1.70
Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol (2009) 1.67
The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci U S A (1997) 1.64
Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol (2000) 1.52
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047). J Med Chem (2009) 1.50
Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J (1996) 1.48
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics (2007) 1.41
A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur J Immunol (1996) 1.35
The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci (2011) 1.35
Lack of proteasome active site allostery as revealed by subunit-specific inhibitors. Mol Cell (2001) 1.34
Proteasomes play an essential role in thymocyte apoptosis. EMBO J (1996) 1.30
Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics (2008) 1.29
Beta 2 subunit propeptides influence cooperative proteasome assembly. J Biol Chem (2002) 1.28
Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. J Mol Biol (2007) 1.27
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma. Clin Cancer Res (2013) 1.27
Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J Biol Chem (1996) 1.27
Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol (2010) 1.21
Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J Immunol (2004) 1.21
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit. Biochem J (2010) 1.18
Specific cell-permeable inhibitor of proteasome trypsin-like sites selectively sensitizes myeloma cells to bortezomib and carfilzomib. Chem Biol (2011) 1.13
Novel propeptide function in 20 S proteasome assembly influences beta subunit composition. J Biol Chem (2000) 1.11
Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J Immunol (2005) 1.09
Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors. Cardiovasc Res (2009) 1.07
Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity. Curr Opin Immunol (2011) 1.05
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes. Chem Biol (1999) 0.97
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors. J Leukoc Biol (2012) 0.96
Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci U S A (1999) 0.96
Targeting the ubiquitin+proteasome system in solid tumors. Semin Hematol (2012) 0.95
Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits. Eur J Immunol (1997) 0.94
Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients. Inflamm Bowel Dis (2009) 0.93
Inhibitors of the immunoproteasome: current status and future directions. Curr Pharm Des (2013) 0.92
Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses. J Immunol (2013) 0.92
Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol (2012) 0.91
Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines. J Immunol (1998) 0.89
Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system. FEBS Lett (1994) 0.86
Subcellular distribution and dynamics of active proteasome complexes unraveled by a workflow combining in vivo complex cross-linking and quantitative proteomics. Mol Cell Proteomics (2012) 0.86
Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis. J Neurochem (2012) 0.85
Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells. Chembiochem (2012) 0.85
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes. Bioorg Med Chem (2011) 0.83
Quantifying cross-tissue diversity in proteasome complexes by mass spectrometry. Mol Biosyst (2010) 0.83
The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexes. PLoS One (2012) 0.82
Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome. J Med Chem (2013) 0.81
Adult human liver contains intermediate-type proteasomes with different enzymatic properties. Ann Hepatol (2014) 0.80
Gel-based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines. Proteomics Clin Appl (2011) 0.80
A FRET-based approach for identification of proteasome catalytic subunit composition. Mol Biosyst (2014) 0.79
Activity-based imaging probes of the proteasome. Cell Biochem Biophys (2013) 0.79
Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors. Eur J Med Chem (2012) 0.78
Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities. Age (Dordr) (2013) 0.78
Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data. J Zhejiang Univ Sci B (2013) 0.76
Comparison of dyes for easy detection of extracellular cellulases in fungi. Mycobiology (2007) 2.77
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology (2006) 2.43
The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med (2003) 1.81
Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol (2013) 1.49
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem (2003) 1.44
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants. Pharmacogenet Genomics (2007) 1.39
LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem Biol (2007) 1.35
Hepatic uptake of the novel antifungal agent caspofungin. Drug Metab Dispos (2005) 1.05
Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study. J Mass Spectrom (2008) 1.00
Targeted degradation of the aryl hydrocarbon receptor by the PROTAC approach: a useful chemical genetic tool. Chembiochem (2007) 0.97
Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg (2004) 0.96
Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res (2014) 0.95
A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells. Mol Pharm (2012) 0.95
Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes. Yonsei Med J (2010) 0.95
Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations. J Phys Chem B (2010) 0.95
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors. Cancer Chemother Pharmacol (2009) 0.95
Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors. Clin Cancer Res (2011) 0.95
A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Mol Endocrinol (2007) 0.94
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50. Mol Cancer Ther (2009) 0.93
Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives. ACS Chem Biol (2013) 0.93
Inhibitors of the immunoproteasome: current status and future directions. Curr Pharm Des (2013) 0.92
Phase I and pharmacokinetic study of IHL-305 (PEGylated liposomal irinotecan) in patients with advanced solid tumors. Cancer Chemother Pharmacol (2012) 0.91
Development of peptide-based reversing agents for p-glycoprotein-mediated resistance to carfilzomib. Mol Pharm (2012) 0.91
OxyR regulon controls lipid peroxidation-mediated oxidative stress in Escherichia coli. J Biochem Mol Biol (2002) 0.90
Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus. Nucleic Acid Ther (2011) 0.89
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin. J Biol Chem (2011) 0.86
Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome. Clin Exp Gastroenterol (2008) 0.85
Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells. Chembiochem (2012) 0.85
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. J Med Chem (2014) 0.84
Genetic analysis of 10 unrelated Korean families with p22-phox-deficient chronic granulomatous disease: an unusually identical mutation of the CYBA gene on Jeju Island, Korea. J Korean Med Sci (2009) 0.84
Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer. Biochem Pharmacol (2013) 0.84
Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review. Ann Lab Med (2013) 0.83
Adult-derived stem cells and their potential for use in tissue repair and molecular medicine. J Cell Mol Med (2005) 0.83
A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes. Bioorg Med Chem (2011) 0.83
Impact of linker length on the activity of PROTACs. Mol Biosyst (2010) 0.83
Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway. Mol Biosyst (2012) 0.83
Molecular analysis of miscarriage products using multiplex ligation-dependent probe amplification (MLPA): alternative to conventional karyotype analysis. Arch Gynecol Obstet (2014) 0.82
Crystallization-induced properties from morphology-controlled organic crystals. Acc Chem Res (2014) 0.81
Jostling for position: optimizing linker location in the design of estrogen receptor-targeting PROTACs. ChemMedChem (2010) 0.81
Targeted Degradation of Proteins by PROTACs. Curr Protoc Chem Biol (2010) 0.81
Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2012) 0.80
Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients. J Am Coll Nutr (2010) 0.80
A FRET-based approach for identification of proteasome catalytic subunit composition. Mol Biosyst (2014) 0.79
Attenuation of extracellular acidic pH-induced cyclooxygenase-2 expression by nitric oxide. Mol Cells (2005) 0.79
Development of a high-yield technique to isolate spermatogonial stem cells from porcine testes. J Assist Reprod Genet (2014) 0.79
Intensive exercise reduces the fear of additional falls in elderly people: findings from the Korea falls prevention study. Korean J Intern Med (2012) 0.78
PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer. PLoS One (2013) 0.78
Statistical methods for assays with limits of detection: Serum bile acid as a differentiator between patients with normal colons, adenomas, and colorectal cancer. J Carcinog (2011) 0.78
Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy. AAPS J (2015) 0.78
Prenatal diagnosis of partial trisomy 3q resulting from t(3;14) in a fetus with multiple anomalies including vermian hypoplasia. Gene (2012) 0.78
Genome-wide screening of severe male factor infertile patients using BAC-array comparative genomic hybridization (CGH). Gene (2012) 0.77
Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening. J Med Chem (2015) 0.77
The immunoproteasome as a therapeutic target for hematological malignancies. Curr Cancer Drug Targets (2014) 0.77
SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms. Bioorg Med Chem Lett (2006) 0.77
Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2. Biochem J (2012) 0.77
Oxalomalate, a competitive inhibitor of NADP+ -dependent isocitrate dehydrogenase, regulates lipid peroxidation-mediated apoptosis in U937 cells. Free Radic Res (2005) 0.76
Carbohydrate intake interacts with SNP276G>T polymorphism in the adiponectin gene to affect fasting blood glucose, HbA1C, and HDL cholesterol in Korean patients with type 2 diabetes. J Am Coll Nutr (2013) 0.76
Siblings with opposite chromosome constitutions, dup(2q)/del(7q) and del(2q)/dup(7q). Gene (2013) 0.76
Bisphenol-A Concentrations from Leiomyoma Patients by LC/MS. Toxicol Res (2011) 0.76
Tumor Vascular Permeability Pattern Is Associated With Complete Response in Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.75
1'-Ethyl-sulfanyl-1,1'-bicyclo-hexyl-2-one. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies. Cancer Chemother Pharmacol (2014) 0.75
Value of Dynamic Contrast-Enhanced MRI to Detect Local Tumor Recurrence in Primary Head and Neck Cancer Patients. Medicine (Baltimore) (2016) 0.75
PROTAC-induced proteolytic targeting. Methods Mol Biol (2012) 0.75
[5-Hydroxy-3-phenyl-1-(pyridin-2-yl)pyrazol-5-olato]diphenylboron. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Synthesis of a p-type semiconducting phenothiazine exfoliatable layered crystal. Langmuir (2013) 0.75
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors. Eur J Clin Pharmacol (2013) 0.75
Understanding, benefits and difficulties of home medicines review - patients' perspectives. Aust Fam Physician (2015) 0.75
[The inhibitory effect of curcumin on the growth of human colon cancer cells (HT-29, WiDr) in vitro]. Korean J Gastroenterol (2005) 0.75
Selective perborate signaling by deprotection of fluorescein and resorufin acetates. Org Lett (2010) 0.75
Arterial hyperintensity on BLADE fluid-attenuated inversion recovery images (FLAIR) in hyperacute territorial infarction: comparison with conventional FLAIR. Eur Radiol (2014) 0.75
A rapid and simple PCR-based method for analysis of transgenic fish using a restricted amount of fin tissue. Transgenic Res (2003) 0.75
Cobalt chloride stimulates phosphoinositide 3-kinase/Akt signaling through the epidermal growth factor receptor in oral squamous cell carcinoma. Biocell (2010) 0.75
Vertical crystallization of C60 nanowires by solvent vapor annealing process. ACS Nano (2013) 0.75
Pd-catalyzed cycloisomerization of 4-aza-1,6-enynes to 3-aza-bicyclo[4.1.0]hept-2-enes. Chemistry (2014) 0.75
Silicon switch approach in TRPV1 antagonist MK-056 and its analogues. Bioorg Med Chem (2009) 0.75